This Viewpoint discusses the need to improve opioid use disorder treatment by developing a validated measure of craving, addressing variability in craving, and examining craving across the treatment trajectory.
No takes yet. Share an insight, caveat, or question.
Kleykamp et al. (2019) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: